CNN: UC neurologist discusses epilepsy drugs and risk of birth defects
A CNN story highlighting new research on medication used to control epileptic seizures features comments from David Ficker, MD, professor in the Department of Neurology and Rehabilitation Medicine in the UC College of Medicine and a UC Health neurologist with the UC Gardner Neuroscience Institute.
The study looks at anti-epileptic drugs associated with an increased risk of birth defects.
Ficker, who is also on the professional advisory board for the Epilepsy Foundation, says studies support avoiding certain anti-epileptic drugs in pregnancy.
Related Stories
'Time is brain' again, now for control of intracerebral hemorrhage
February 5, 2026
MedPage Today highlighted research led by the University of Cincinnati's Joseph Broderick that found administering a synthetic protein can reduce bleeding and improve outcomes for certain patients at the highest risk of continued bleeding following a type of stroke called an intracerebral hemorrhage (ICH).
Study: Synthetic protein potentially improves outcomes for certain subgroups following intracerebral hemorrhage
February 4, 2026
The University of Cincinnati’s Joseph Broderick, MD, presented results from the FASTEST trial at the International Stroke Conference, simultaneously published in The Lancet, that found administering a synthetic protein, recombinant Factor VIIa, can reduce bleeding and potentially improve outcomes for certain patients at the highest risk of continued bleeding following an intracerebral hemorrhage.
Trials find electromagnetic pulses aid stroke recovery
January 30, 2026
The University of Cincinnati's Joseph Broderick, MD, was featured in a U.S. News & World Report article commenting on new research being presented at the International Stroke Conference that found stroke survivors might benefit from electromagnetic pulses that stimulate their brains and spur on their recovery.